Chemfab Alkalis Ltd Quarterly Results, Profit & Loss, Balance Sheet (CHEMFAB) | Stocksigma

Chemfab Alkalis Ltd (CHEMFAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Chemfab Alkalis Ltd reported sales of ₹75.61 Cr, operating profit of ₹7.04 Cr (OPM 9.31%) and net profit of ₹-2.11 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

CHEMFAB quarterly results (₹ Cr)
Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	83.62	92.32	91.54	76.56	68.14	74.78	73.16	75.61
Expenses	71.71	78.98	80.24	71.1	66.21	66.26	63.03	68.57
Operating Profit	11.91	13.34	11.3	5.46	1.93	8.52	10.13	7.04
OPM	14.24%	14.45%	12.34%	7.13%	2.83%	11.39%	13.85%	9.31%
Other Income	2.55	-8.51	1.36	1.76	2.77	2.8	2.08	0.37
Interest	1.2	1.57	1.57	1.94	2.03	2.14	2.21	2.46
Depreciation	9.62	10.61	6.39	6.61	7.47	7.95	7.78	7.9
Profit before tax	3.64	-7.35	4.7	-1.33	-4.8	1.23	2.22	-2.95
Tax	48.08%	25.03%	45.74%	51.13%	-7.08%	60.16%	-158.11%	-28.14%
Net Profit	1.88	-9.19	2.55	-2.01	-4.45	0.48	5.73	-2.11
EPS in Rs	1.32	-6.4	1.78	-1.4	-3.1	0.33	3.99	-1.47

CHEMFAB profit & loss, annual (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	272	331	327	334	311	292
Expenses	215	221	273	290	284	264
Operating Profit	57	111	55	44	27	28
OPM	21%	33%	17%	13%	9%	9%
Other Income	6	2	9	-3	9	8
Interest	1	1	2	6	8	9
Depreciation	22	23	22	36	28	31
Profit before tax	39	89	39	0	0	-4
Tax	26%	28%	33%	2,210%	1,615%	-
Net Profit	29	65	26	-7	-3	0
EPS in Rs	20.34	45.54	18.5	-4.83	-2.39	-0.25
Dividend Payout	6%	3%	7%	-26%	-52%	-

CHEMFAB balance sheet (₹ Cr)
Metric	Mar 2024	Mar 2025	Sep 2025	Mar 2026	Sep 2026
Equity Capital	14	14	14	14	14
Reserves	373	366	365	361	363
Borrowings	20	84	109	126	144
Other Liabilities	93	57	79	76	61
Total Liabilities	500	522	567	577	582
Fixed Assets	247	317	314	387	380
CWIP	74	36	63	31	33
Investments	5	16	0	14	15
Other Assets	174	152	190	146	155
Total Assets	500	522	567	577	582

CHEMFAB cash flows (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	55	93	31	40	38
Cash from Investing Activity	-21	-48	-110	-86	-81
Cash from Financing Activity	-25	-9	16	59	31
Net Cash Flow	9	36	-62	13	-12
Free Cash Flow	35	40	-60	-71	-38
CFO/OP	107%	97%	74%	104%	140%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit	107	97	74	104	142

CHEMFAB ratios
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	29	24	24	23	28
Inventory Days	54	89	60	100	92
Days Payable	92	145	101	118	111
Cash Conversion Cycle	-9	-32	-18	4	9
Working Capital Days	5	7	-24	28	-1
ROCE	13%	28%	10%	3%	1%